The Center of Excellence for the Acceleration of Harm Reduction (CoEHAR) is among the contributors for the drafting of the BECA Report by the Special Committee on Cancer of the European Parliament. This is another important milestone for CoEHAR and a recognition of the international activities of the Center in the scientific field.
The report was due because of the difficulties that emerged by the pandemic, which put a strain on the national health systems of numerous members of the EU, and a delay in the prevention and treatment of many diseases.
Prevention, early diagnosis, treatment, improvement of the quality of life. Those the main areas of interventions underlined by the European plan.
Among the recommendations preventing the behaviours or habits, such as cigarette smoking, that can aggravate the condition.
“It is a privilege and a great recognition to be able to contribute to the planning of public policies aimed at reducing smoking habits. Cancer is a disease that can be fought only with early diagnosis and innovative treatments. A condition exacerbated by harmful behaviours, such as cigarette smoking. We hope – explained the Founder of CoEHAR Riccardo Polosa – that this can be one step forward for the recognition and definitive application of harm reduction strategies in the battle against smoking”.
To follow, the letter from the Special Committee on Beating Cancer Plan of the European Parliament,for having participated to their public consultation in February 2021 aimed at gathering opinions on the impact of COVID on cancer prevention measures, associated health services, cancer patients and sector research.
An ambitious project, which intends to create a network to promote the sharing knowledge on cancer and to develop transnational health initiatives.
The Covid-19 epidemic emphasized the limits of the European Health System and the complexities that occurred in the field of prevention and diagnosis, with restrictions and the fear of getting infected that stopped thousands of people from carrying out the normal routine checks.
But there is one bright side. The challenging circumstances enabled the development of procedures that will contribute to improving the fight against cancer.